Search icon
Learn, Analyse & Invest
only with
Orca logoArrow icon
+91
Download Orca
orca play storeorca apple store
To access realtime data for Reliance Industries Ltd, and use advance features for tradingRegisterorLogin to Orca.

Medicamen Biotech Ltd.

Medicamen Biotech

0.00

0.00 (0.00)%

NSE

BSE

EX-DatePurpose
26 06 2021 Audited Results
13 08 2021 Quarterly Results
03 11 2021 Quarterly Results
08 02 2022 Quarterly Results
25 05 2022 Final Dividend & Audited Results
01 08 2022 Preferential Issue of shares
10 08 2022 Quarterly Results
11 11 2022 Quarterly Results
10 02 2023 Quarterly Results
29 05 2023 Final Dividend & Audited Results
08 08 2023 Quarterly Results
10 11 2023 Quarterly Results
12 02 2024 Quarterly Results
14 11 2024 Quarterly Results
11 02 2025 Quarterly Results
26 02 2025 Preferential Issue of shares & Inter alia, to consider and approve a proposal for raising of funds by way of issuance of one or more instruments including equity shares/convertible securities either by way of Preferential Issue/Right Issue/QIP or any other mode.
30 05 2025 Final Dividend & Audited Results
12 08 2025 Quarterly Results
14 11 2025 Quarterly Results
13 02 2026 Quarterly Results

News

03-JUN-2025

Medicamen Biotech gets USFDA’s approval for Bortezomib for injection

This achievement marks a major step forward in its commitment to enter in regulated markets

03:30 PM
03-APR-2025

Medicamen Biotech signs contract for CDMO with XGX pharma

Medicamen will develop 6 products and will do manufacturing of these products for European company

04:17 PM
10-MAR-2025

Medicamen Biotech enters into understanding with South African business conglomerate

The company has entered into an understanding for registering and marketing its products in the region

11:18 AM
12-AUG-2022

Medicamen Biotech inks agreement with Vital Pharma Nordic

VPN operate in the Nordic region now expanding internationally

03:19 PM
Enrich money logo